The FMBA announced AI's help in finding mutations for cancer vaccines

Artificial intelligence (AI) helps specialists find mutations in the human genome to create personalized vaccines against cancer. This was announced on June 4 by Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA) of Russia, on the sidelines of the St. Petersburg International Economic Forum (SPIEF).

"We use predictive computing algorithms based on machine learning methods. We use the results of sequencing the RNA of a human tumor and its blood for the material, and assessing the differences between the genome of the person himself and the genome of his tumor," the head of the agency said in an interview with RT.

According to Skvortsova, despite the use of machine learning technologies, the agency's specialists check the final research results manually. She added that it takes 42 days to create a cancer vaccine, after which the drug is tested for another seven days.

"All our lives we carry in our soul the burden and memory of those who could not be saved"

Denis Davydov, head of the Burdenko Military Medical Center, spoke about the difficult choice, the new nature of the wounds and the gratitude from the fighters

On January 1, Marina Sekacheva, Director of the Institute of Personalized Oncology at the First Moscow State Medical University, MD, Professor, told Izvestia that the AI created at Sechenov University allows for automatic analysis of biopsy materials of kidney tumors and assess the degree of their aggressiveness more accurately than previous methods. AI is already being used to interpret MRI and CT data, predict response to therapy, and select individual treatment regimens.